Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Jul;72(1):304–315. doi: 10.1172/JCI110970

Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.

E S Kleinerman, A J Schroit, W E Fogler, I J Fidler
PMCID: PMC1129186  PMID: 6348087

Abstract

Human peripheral blood mononuclear cells from normal donors obtained by separation on a Percoll gradient were incubated with free or liposome-entrapped lymphokines produced from concanavalin A-stimulated lymphocytes and then were tested for cytotoxic activity against tumor cells. The treated monocytes lysed tumorigenic melanoma and glioblastoma target cells, but had no effect on three types of nontumorigenic target cells. The activation of monocytes to become tumoricidal was caused by macrophage-activating factor (MAF) and not by contamination with endotoxins, concanavalin A, or interferon. The endocytosis of liposomes containing MAF, but not of those containing control supernatants, led to the activation of cytotoxic properties in the monocytes. Activation by liposome-encapsulated MAF was very efficient and required less than 1/800th of the amount of free MAF necessary to achieve the same levels of cytotoxicity. Thus, the encapsulation of mitogen-induced MAF in liposomes could provide an effective approach for the activation of blood monocytes in situ.

Full text

PDF
304

Images in this article

310FIGURE 2
on p.310

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cameron D. J., Churchill W. H. Cytotoxicity of human macrophages for tumor cells. Enhancement by human lymphocyte mediators. J Clin Invest. 1979 May;63(5):977–984. doi: 10.1172/JCI109398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Churchill W. H., Jr, Piessens W. F., Sulis C. A., David J. R. Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. J Immunol. 1975 Sep;115(3):781–786. [PMC free article] [PubMed] [Google Scholar]
  3. Fidler I. J. Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants. J Natl Cancer Inst. 1975 Nov;55(5):1159–1163. doi: 10.1093/jnci/55.5.1159. [DOI] [PubMed] [Google Scholar]
  4. Fidler I. J., Barnes Z., Fogler W. E., Kirsh R., Bugelski P., Poste G. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res. 1982 Feb;42(2):496–501. [PubMed] [Google Scholar]
  5. Fidler I. J., Darnell J. H., Budmen M. B. Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A. Cancer Res. 1976 Oct;36(10):3608–3615. [PubMed] [Google Scholar]
  6. Fidler I. J., Raz A., Fogler W. E., Hoyer L. C., Poste G. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes. Cancer Res. 1981 Feb;41(2):495–504. [PubMed] [Google Scholar]
  7. Fidler I. J., Raz A., Fogler W. E., Kirsh R., Bugelski P., Poste G. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res. 1980 Dec;40(12):4460–4466. [PubMed] [Google Scholar]
  8. Fidler I. J. Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science. 1980 Jun 27;208(4451):1469–1471. doi: 10.1126/science.7384789. [DOI] [PubMed] [Google Scholar]
  9. Fischer D. G., Hubbard W. J., Koren H. S. Tumor cell killing by freshly isolated peripheral blood monocytes. Cell Immunol. 1981 Mar 1;58(2):426–435. doi: 10.1016/0008-8749(81)90235-5. [DOI] [PubMed] [Google Scholar]
  10. Fogler W. E., Raz A., Fidler I. J. In situ activation of murine macrophages by liposomes containing lymphokines. Cell Immunol. 1980 Jul 15;53(1):214–219. doi: 10.1016/0008-8749(80)90440-2. [DOI] [PubMed] [Google Scholar]
  11. Giard D. J., Aaronson S. A., Todaro G. J., Arnstein P., Kersey J. H., Dosik H., Parks W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973 Nov;51(5):1417–1423. doi: 10.1093/jnci/51.5.1417. [DOI] [PubMed] [Google Scholar]
  12. Gmelig-Meyling F., Waldmann T. A. Separation of human blood monocytes and lymphocytes on a continuous Percoll gradient. J Immunol Methods. 1980;33(1):1–9. doi: 10.1016/0022-1759(80)90077-0. [DOI] [PubMed] [Google Scholar]
  13. Jett J. R., Mantovani A., Herberman R. B. Augmentation of human monocyte-mediated cytolysis by interferon. Cell Immunol. 1980 Sep 1;54(2):425–434. doi: 10.1016/0008-8749(80)90222-1. [DOI] [PubMed] [Google Scholar]
  14. Kleinerman E. S., Zwelling L. A., Howser D., Barlock A., Young R. C., Decker J. M., Bull J., Muchmore A. V. Defective monocyte killing in patients with malignancies and restoration of function during chemotherapy. Lancet. 1980 Nov 22;2(8204):1102–1105. doi: 10.1016/s0140-6736(80)92540-4. [DOI] [PubMed] [Google Scholar]
  15. Mantovani A., Bar Shavit Z., Peri G., Polentarutti N., Bordignon C., Sessa C., Mangioni C. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites. Clin Exp Immunol. 1980 Mar;39(3):776–784. [PMC free article] [PubMed] [Google Scholar]
  16. Mantovani A., Dean J. H., Jerrells T. R., Herberman R. B. Augmentation of tumoricidal activity of human monocytes and macrophages by lymphokines. Int J Cancer. 1980 Jun 15;25(6):691–699. doi: 10.1002/ijc.2910250602. [DOI] [PubMed] [Google Scholar]
  17. Mantovani A., Jerrells T. R., Dean J. H., Herberman R. B. Cytolytic and cytostatic activity on tumor cells of circulating human monocytes. Int J Cancer. 1979 Jan 15;23(1):18–27. doi: 10.1002/ijc.2910230105. [DOI] [PubMed] [Google Scholar]
  18. Mantovani A., Tagliabue A., Dean J. H., Jerrells T. R., Herberman R. B. Cytolytic activity of circulating human monocytes on transformed and untransformed human fibroblasts. Int J Cancer. 1979 Jan 15;23(1):28–31. doi: 10.1002/ijc.2910230106. [DOI] [PubMed] [Google Scholar]
  19. Mukherji B. In vitro assay of spontaneous cytotoxicity by human monocytes and macrophages against tumor cells. J Immunol Methods. 1980;37(3-4):233–247. doi: 10.1016/0022-1759(80)90310-5. [DOI] [PubMed] [Google Scholar]
  20. Papermaster B. W., Holtermann O. A., Rosner D., Klein E., Dao T. Regressions produced in breast cancer lesions by a lymphokine fraction from a human lymphoid cell line. Res Commun Chem Pathol Pharmacol. 1974 Jun;8(2):413–416. [PubMed] [Google Scholar]
  21. Peri G., Polentarutti N., Sessa C., Mangioni C., Mantovani A. Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin. Int J Cancer. 1981 Aug 15;28(2):143–152. doi: 10.1002/ijc.2910280206. [DOI] [PubMed] [Google Scholar]
  22. Poste G., Kirsh R., Fogler W. E., Fidler I. J. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. Cancer Res. 1979 Mar;39(3):881–892. [PubMed] [Google Scholar]
  23. Poste G., Kirsh R. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages. Cancer Res. 1979 Jul;39(7 Pt 1):2582–2590. [PubMed] [Google Scholar]
  24. Poste G., Papahadjopoulos D. Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells. Proc Natl Acad Sci U S A. 1976 May;73(5):1603–1607. doi: 10.1073/pnas.73.5.1603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ruco L. P., Meltzer M. S. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures. J Immunol. 1977 Sep;119(3):889–896. [PubMed] [Google Scholar]
  26. Salvin S. B., Youngner J. S., Nishio J., Neta R. Tumor suppression by a lymphokine released into the circulation of mice with delayed hypersensitivity. J Natl Cancer Inst. 1975 Nov;55(5):1233–1236. doi: 10.1093/jnci/55.5.1233. [DOI] [PubMed] [Google Scholar]
  27. Schroit A. J., Fidler I. J. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res. 1982 Jan;42(1):161–167. [PubMed] [Google Scholar]
  28. Snyderman R., Meadows L., Holder W., Wells S., Jr Abnormal monocyte chemotaxis in patients with breast cancer: evidence for a tumor-mediated effect. J Natl Cancer Inst. 1978 Apr;60(4):737–740. doi: 10.1093/jnci/60.4.737. [DOI] [PubMed] [Google Scholar]
  29. Sone S., Moriguchi S., Shimizu E., Ogushi F., Tsubura E. In vitro generation of tumoricidal properties in human alveolar macrophages following interaction with endotoxin. Cancer Res. 1982 Jun;42(6):2227–2231. [PubMed] [Google Scholar]
  30. Sone S., Poste G., Fidler I. J. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines. J Immunol. 1980 May;124(5):2197–2202. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES